Results 311 to 318 of about 12,995,996 (318)

Modern treatment of haemophilia: choice of products for the treatment of haemophilia A and B

Haemophilia, 1995
openaire   +3 more sources

Multicentre, randomized, open‐label study of on‐demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects

Haemophilia, 2014
L. Valentino, L. Rusen, I. Elezović, L. Smith, J. Korth-Bradley, P. Rendo   +5 more
semanticscholar   +1 more source

Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open‐label, uncontrolled, multicentre, phase III study

Haemophilia, 2014
J. Windyga, T. Lissitchkov, O. Stasyshyn, V. Mamonov, H. Ghandehari, M. Chapman, S. Fritsch, W. Wong, B. Pavlova, B. Abbuehl   +9 more
semanticscholar   +1 more source

Recombinant factor IX (BAX326 ) in previously treated paediatric patients with haemophilia B: a prospective clinical trial

Haemophilia, 2015
T. Urasiński, O. Stasyshyn, T. Andreeva, L. Rusen, F. Perina, M. Oh, M. Chapman, B. Pavlova, B. Valenta-Singer, B. Abbuehl   +9 more
semanticscholar   +1 more source

Future developments in the treatment of haemophilia B

Haemophilia, 1995
openaire   +3 more sources

Screening of haemophilia carriers in moderate and severe haemophilia A and B: Prevalence and determinants

Haemophilia, 2018
W. Bernard, C. Lambert, S. Henrard, C. Hermans   +3 more
openaire   +2 more sources

Comparative study of the prevalence of clotting factor deficiency in carriers of haemophilia A and haemophilia B

Haemophilia, 2017
A. Boban, C. Lambert, N. Lannoy, C. Hermans   +3 more
semanticscholar   +1 more source

THE IDENTIFICATION OF HAEMOPHILIA B MUTATIONS

1987
openaire   +2 more sources